Pharma

winners-of-glaxosmithkline-gsk-discovery-fast-track-competition-will-partner-with-investigators-on-gsk-s-discovery-partnerships-with-academia-dpac-team

GSK launches discovery competition for researchers

  • Europe
    • |
  • News

Singapore: GlaxoSmithKline (GSK) launched Discovery Fast Track, a competition designed to accelerate the translation of academic research into novel therapies. Winners of the competition will partner with investigators on GSK's Discovery... Read more

pfizer-stops-its-phase-iii-study-of-inotuzumab-ozogamicin

Pfizer halts 'useless' phase III lymphoma study


  • US
    • |
  • News
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: Pfizer has discontinued its phase III randomized, open-label, two-arm study (B1931008) evaluating the safety and... Read more

alchemia-provides-update-on-fondaparinux-its-new-collaboration-with-merck-serono-and-its-current-ha-irinotecan-phase-iii-clinical-trial

Alchemia provides update on its core projects


  • Australia
    • |
  • Company Results
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: Australia-based Alchemia has provided commercial update on four of its key projects, including its marketed drug... Read more

oramed-unstable-diabetes-drug-is-a-hit

Oramed ‘unstable diabetes’ drug is a hit

  • Rest of Asia
    • |
  • News
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: Oramed Pharmaceuticals' article titled, ‘Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with... Read more

us-fda-recommends-allergan-s-juvederm-voluma-for-cheek-augmentation

FDA nod for Allergan cheek augmentation drug

  • US
    • |
  • Regulatory
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: The US FDA advisory committee has recommended Juvederm Voluma, by Allergan, as a safe and effective treatment option for cheek... Read more

teva-pharma-to-close-its-206-000-square-feet-sellersville-facility-by-2017

Teva to shut down US site, cut many jobs

  • US
    • |
  • News
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: Teva Pharmaceutical Industries decided to close its manufacturing and research facility in Sellersville, Bucks County, US, by... Read more

abide-therapeutics-entered-into-an-agreement-with-merck-msd-to-discover-develop-and-commercialize-small-molecule-therapies-for-type-2-diabetes

Merck to pay up to $430 mn to Abide for diabetes deal

  • US
    • |
  • News
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: Abide Therapeutics, a biopharmaceutical company pioneering innovative approaches to selectively target a group of enzymes known... Read more

pfizer-us-may-reach-a-final-decision-on-whether-or-not-to-split-itself-into-brand-name-and-generics-businesses-only-by-2016

Pfizer US may split its generics business

  • US
    • |
  • News
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: Pfizer, US, is contemplating the thought of splitting itself into brand name and generics businesses. Mr Frank D'Amelio, chief... Read more

tianyin-pharmaceutical-completed-construction-of-its-53-000-square-meters-qionglai-facility-qlf

Tianyin TCM raw material processing plant is ready

  • China
    • |
  • News
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

‎Singapore: Tianyin Pharmaceutical, a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese... Read more

abbvie-and-intermune-attempt-to-to-access-company-information-as-per-ema-s-access-to-documents-policy-has-been-thwarted-by-eu-court

EU court thwarts AbbVie attempt to access data

  • Europe
    • |
  • Regulatory
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: European Medicines Agency (EMA) has been ordered by the General Court of the European Union not to provide documents as part... Read more

fda-approves-pjia-drug

First FDA nod for juvenile arthritis drug in 5 years

  • US
    • |
  • Regulatory
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: Genentech, a member of the Roche Group received approval for its polyarticular juvenile idiopathic arthritis (PJIA) drug Actemra... Read more

deficiencies-in-documentation-and-validation-of-quality-testing-procedures-leads-fda-to-reject-gilead-hiv-ndas-for-elvitegravir-and-cobicistat

Lack of documents leads FDA to reject Gilead HIV NDAs

  • US
    • |
  • Regulatory
    • |
  • By BioSpectrum Bureau
    • |
  • 0 Comment

Singapore: Gilead Sciences received complete response letters from the US FDA for its New Drug Applications (NDAs) for elvitegravir and... Read more

4 5 7 9 10

Special Features

Editor's Pick

Featured Links

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X